Skip to main content
. Author manuscript; available in PMC: 2016 Apr 7.
Published in final edited form as: J Sex Med. 2009 Mar;6(Suppl 3):269–278. doi: 10.1111/j.1743-6109.2008.01184.x

Figure 1.

Figure 1

Mean voltage-dependent erectile responses (intracavernosal pressure/mean arterial pressure [ICP/ MAP]) of lean and obese-diabetic Zucker rats with or without rosuvasta-tin treatment. Treatment was 5 mg/kg/day rosuvastatin or saline, as control, for 3 days prior to the assessment of voltage-dependent erectile response. Erectile function was assessed and cavernosal tissue was removed as described previously [26–28]. †Statistical difference from the lean control; *statistical difference from obese-control response, P < 0.05. Reported are means ± standard error of the mean for four to six animals in each group.